[1]
Neema Kumari et al. 2024. Investigating the Role of a T-type Calcium Channel Antagonist (TTA-A2) as a Potential Adjuvant of Paclitaxel in Chemotherapy. Medicine and Medical Research: New Perspectives Vol. 3. (Aug. 2024), 90–115. DOI:https://doi.org/10.9734/bpi/mmrnp/v3/1813.